Protective strategies against ischemic injury of the liver.
This article summarizes strategies to protect the liver from injuries caused by ischemia and reperfusion. Three different sections (i.e., surgical and pharmacologic strategies and gene therapy) present approaches to enhance the survival and viability of the liver in various surgical procedures including liver transplantation. The first section reviews approaches using surgical interventions such as ischemic preconditioning and intermittent clamping. Their protective effects are discussed with respect to the mechanism of injury. In the second section, pharmacologic agents targeting microcirculation, oxidative stress, proteases, and inflammation are described. Mechanisms of injury and their suppression by a wide variety of drugs are discussed. The third section focuses on gene therapy. Potential target genes have been identified (e.g., superoxide dismutase or heme oxygenase). Animal experiments in which the liver injury is reduced successfully may pave the way to novel strategies applied to different liver diseases in humans.
Selzner
Nazia
N
Department of Surgery, University Hospital of Zurich, Zurich, Switzerland.
Rudiger
Hannes
H
Graf
Rolf
R
Clavien
Pierre-Alain
PA
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D015316:Genetic Therapy; D006801:Humans; D007511:Ischemia / Q000473:pathology*; D019194:Ischemic Preconditioning; D008099:Liver / Q000098:blood supply* / Q000473:pathology; D009926:Organ Preservation; D010431:Pentoxifylline / Q000627:therapeutic use; D011480:Protease Inhibitors / Q000627:therapeutic use; D015427:Reperfusion Injury / Q000517:prevention & control*
D000975:Antioxidants; D011480:Protease Inhibitors; D010431:Pentoxifylline